M. Yagci Et Al. , "The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies," TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, pp.251-256, 2015
Yagci, M. Et Al. 2015. The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies. TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3 , 251-256.
Yagci, M., Suyam, E., & Cakar, M. K., (2015). The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies. TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, 251-256.
Yagci, ABDULLAH, Elif Suyam, And Merih Kizil Cakar. "The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies," TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, 251-256, 2015
Yagci, ABDULLAH M. Et Al. "The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies." TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, pp.251-256, 2015
Yagci, M. Suyam, E. And Cakar, M. K. (2015) . "The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies." TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, pp.251-256.
@article{article, author={ABDULLAH MÜNCİ YAĞCI Et Al. }, title={The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2015, pages={251-256} }